Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

DuPont

Divest the Clean Technologies, Biomaterials, and Solamet businesses

Not delivered by the deadline

AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.

Announced
15 Mar 2021
Due
30 Jun 2021
Checked
12 Oct 2026
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“Divestitures of those businesses are expected to occur during 1H 2021 subject to regulatory approval and customary closing conditions.”
  • SourceDuPont Form 8-K press release, 2021-03-15
  • FilingSEC filing index
  • Deadline as stated1H 2021
  • Deadline used30 Jun 2021, the last day of the stated period
  • TypeTransaction
  • Permanent referenceKI-C-2021-DD-007446
    Cite as https://keptindex.org/c/KI-C-2021-DD-007446/ — this address never changes.

What we found

Evidence strength A What the grades mean

DuPont failed to divest the Clean Technologies, Biomaterials, and Solamet businesses by the 1H 2021 deadline, with these divestitures occurring in the second half of 2021 or later.

  • A
    DuPont 10-K filed 2022-02-11 Regulatory filing · published 11 Feb 2022 · retrieved 12 Oct 2026 · kept permanently by the SEC · fingerprint 3f78c629f0fa
    “To date, the following divestitures of businesses held within Corporate have occurred: •Clean Technologies on December 31, 2021; •Solamet® in the third quarter 2021;” ✓ confirmed on the page
  • A
    DuPont 10-Q filed 2022-08-04 Regulatory filing · published 4 Aug 2022 · retrieved 12 Oct 2026 · kept permanently by the SEC · fingerprint 506a55cf7152
    “Net sales primarily decreased due to the divestitures of the Biomaterials business in May 2022” ✓ confirmed on the page

Market reaction: the shares moved +2.4% against the S&P 500 over the three sessions around the disclosure (10 Feb 2022 to 15 Feb 2022). What this measures

Checked 12 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Transaction other
Indicative materiality
Medium rules
Action
Divest
Deliverable
Clean Technologies, Biomaterials and Solamet businesses
Language
Expected (“expects”, “plans”)
In the company’s control
Medium
Specificity
High
Conditional
Yes: subject to regulatory approval; customary closing conditions
Depends on
Regulatory, Counterparty

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “Late”.
  4. Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the second check.

Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works

Are you DuPont? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-DD-007446 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.